Bravecto is a topical, prescription flea and tick medication that provides up to 12 weeks of protection against fleas and ticks (black-legged ticks and Asian longhorned ticks) plus up to 8 weeks of protection against American dog ticks.

Bravecto for Cats kills and prevents flea infestations in cats for 12 weeks. It also kills and controls tick infestations (black-legged ticks and Asian longhorned ticks) for 12 weeks, and American dog ticks for up to 8 weeks.

Apply Bravecto for Cats topically as a single dose every 12 weeks following the instructions in the package. It may be administered every 8 weeks in case of potential exposure to American dog ticks.

Cats and kittens 6 months of age or older weighing 2.6 lbs or more

Fluralaner

The most commonly reported adverse reactions of Bravecto for Cats include vomiting, itching, diarrhea, hair loss, decreased appetite, lethargy, and scabs/ulcerated lesions. 

Fluralaner is a member of the isoxazoline class. This class has been associated with neurologic adverse reactions including tremors, ataxia, and seizures. Neurologic adverse reactions have been reported in cats receiving isoxazoline class drugs, even in cats without a history of neurologic disorders. Use with caution in cats with a history of neurologic disorders.

The safety of Bravecto has not been established in breeding, pregnant, and lactating cats.